<DOC>
	<DOCNO>NCT00000901</DOCNO>
	<brief_summary>The purpose study see safe effective give anti-HIV drug combination indinavir ( IDV ) plus stavudine ( d4T ) plus lamivudine ( 3TC ) HIV-infected child . IDV give either powder mixed applesauce capsule give empty stomach .</brief_summary>
	<brief_title>Safety Effectiveness Giving Indinavir Plus Stavudine Plus Lamivudine HIV-Infected Children</brief_title>
	<detailed_description>In multicenter , open-label study patient receive combine drug regimen indinavir , stavudine , lamivudine 48 week . Patients evaluate Weeks 0 , 2 , 4 , every 4 week Week 24 , every 8 week thereafter study completion . [ AS PER AMENDMENT 4/27/99 : The study extend additional 48 week total 96 week . ]</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<criteria>Inclusion Criteria Your child may eligible study he/she : Is 3 15 year old consent parent legal guardian able return child followup visit . Is HIVpositive . Is generally healthy . Is able swallow medication capsule form . Has never take d4T never take 3TC . Agrees use barrier method birth control ( condom ) study . The pill allow study . Exclusion Criteria Your child eligible study he/she : Has serious infection time study entry . Has history severe diarrhea . Is unable take medication study reason . Has history certain serious illness . Has take protease inhibitor ( PIs ) . Has take nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) , efavirenz ( EFV ) , within 2 week prior study entry . Has take certain medication . Is pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Stavudine</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Lamivudine</keyword>
	<keyword>Indinavir</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Viral Load</keyword>
</DOC>